Exploring Selegiline's Role in Treating Schizophrenia: A Fresh Perspective
Selegiline, traditionally known for treating Parkinson's disease and depression, is being explored as a potential therapy for schizophrenia. This article dives into the mechanics of selegiline and its effects on brain chemistry, examining if it could play a part in managing schizophrenia symptoms. We'll look at current research and what the future might hold for selegiline in the mental health landscape. Could it be a game-changer for those with schizophrenia? Discover the possibilities and limitations of this intriguing treatment option.
